Nephrocare Health Services Ltd

Nephrocare Health Services Limited, formerly Nephrocare Health Services Private Limited, will hold a board meeting on November 3, 2026, to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, according to a filing with the BSE Limited and National Stock Exchange of India Limited. The trading window for the company's securities has been closed for designated persons and their immediate relatives from October 1, 2026, until November 5, 2026.

Nephrocare Health Services Limited, formerly Nephrocare Health Services Private Limited, submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as received from KFIN Technologies Limited, its Registrar and Share Transfer Agent.

Nephrocare Health Services Limited, formerly Nephrocare Health Services Private Limited, will close its trading window for designated persons and their immediate relatives from October 1, 2026, due to the existence of unpublished price sensitive information, including the financial results for the quarter and half year ending September 30, 2026, according to a filing with the BSE Limited and National Stock Exchange of India Limited.

Nephrocare Health Services Ltd announced credit rating actions from India Ratings and India Ratings and Research (Ind-Ra) across various bank loan facilities and a term loan. India Ratings upgraded the Bank Loan Facilities - Long -term to IND AA-/Stable and the Bank Loan Facilities - Short -term to IND A1+ / IND AA- / Stable, reaffirmed the Short-Term Rating at IND A1+, and upgraded Bank Loan Facilities to IND AA- with a stable outlook; Ind-Ra upgraded bank loan facilities totaling 2,262.27, affirmed short-term ratings on bank loan facilities totaling 2,700.00, assigned a rating of IND AA-/Stable/IND A1+ to bank loan facilities of 506.63, and provided ratings for additional bank loan facilities of 650 (Citibank N.A.), 400 (HDFC Bank Limited), and 1,650 (Hongkong Shanghai Banking corporation), alongside a term loan of 68.9 from Asian Development Bank, all carrying the IND AA-/Stable/IND A1+ rating, with no other rating agencies or instruments mentioned.

Nephrocare Health Services Limited said its board approved a plan to rationalize and consolidate its step-down subsidiaries in the Philippines to simplify the group's corporate structure and enhance operational efficiencies, according to a regulatory filing on Friday, September 18, 2026. The consolidation, which will be implemented in phases and is subject to regulatory approvals, will not involve any third-party investors or change the company's ultimate economic interest or control over the Philippine operations.

Nephrocare Health Services Limited announced that its overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., has entered into an Asset Transfer Agreement with Renal One Dialysis Corp. for the acquisition of assets related to a dialysis center in Plaridel, Bulacan, Philippines, for a total consideration of PhP 67,200,000, equivalent to approximately INR 10.25 crores.

Nephrocare Health Services Limited announced that its overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., has entered into an Asset Transfer Agreement with Assumption Dialysis Center on August 17, 2026, to acquire assets of a dialysis center in the Philippines for a total consideration of PhP 75,000,000.

Nephrocare Health Services Limited announced that its overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., has entered into an Asset Transfer Agreement dated August 12, 2026, with Juan Nephro Dialysis Center to acquire assets of a dialysis center in Davao City, Philippines, for a consideration of PhP 71,800,000.

Nephrocare Health Services Limited clarified that NEPHROPLUS HEALTH SERVICES KAZAKHSTAN Limited Liability Partnership (“NPHSK LLP”), incorporated in the Republic of Kazakhstan on May 26, 2026, is a step-down subsidiary, not a wholly-owned subsidiary, as previously disclosed; Nephrocare Health Services International Pte. Ltd. (“NHSI”), Singapore, a wholly-owned subsidiary of Nephrocare Health Services Limited, holds 99% of NPHSK LLP’s charter capital, with the remaining 1% held by another participant, and the charter capital totals KZT 5,000,000, approximately USD 10,500.

Nephrocare Health Services Ltd share price ticked higher by 0.28% to Rs 696.15 after the company's net profit inched up 5.27% to Rs 31.97 crore, while revenue from operations slightly gained 6.07% to Rs 281.75 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 72255.77 crore, improving 10.15%. It has improved by 2.19% over last one week and surged by 17.19% in last one month while the market capitalization of Nephrocare Health Services Ltd has remained flat Profit before tax (PBT) of Nephrocare Health Services Ltd stood at Rs 41.03 crore in Q2 FY26, rallying 43.86% year-on-year, and surging by 23.51% quarter-on-quarter. EBITDA came in at Rs 56 crore, expanding by 37.64% YoY and jumping 33.70% sequentially. Total expenses grew marginally by 1.99% to Rs 242.41 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 62.44 crore, inching up 4.71% YoY, while employee benefits expense was at Rs 47.83 crore, easing 4.14% YoY. For the TTM ended FY26, revenue from operations jumped by 32.16% to Rs 998.85 crore, while net profit registered a growth of 14.52% to Rs 76.84 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 16974% to Rs 202.46 crore, and PBT rose 11.47% to Rs 97.47 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 232.58 crore in FY26, as against Rs 135.35 crore in FY25. Nephrocare Health Services Ltd surged by 47.61% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.56% during the same period.